| P/E (FY) | — | Sales (TTM) | — |
| Earnings (TTM) | -$113.3M | ROE | −96.20% |
| Net Margin | — | ROIC | — |
| Debt / Equity | 0.32 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $164.7M | Trading Days | 943 |
| 52W High | 3.60 |
| 52W Low | 1.19 |
| % Off High | −36.67% |
| YTD | 8.06% | 1Y | 56.16% |
| 3Y | −68.89% | Since incept. (ann.) | −28.38% |
| Ann. Volatility (1Y) | 87.09% | Ann. Volatility (3Y) | 79.96% |
| Sharpe (1Y) | 0.94 | Sharpe (3Y) | −0.09 |
| Max Drawdown (1Y) | −36.80% | Max Drawdown (3Y) | −87.83% |
| Beta (3Y, vs SPY) | 2.70 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | $164.1M | — |
| ALEC | Alector, Inc. | $168.8M | — |
| IVVD | Invivyd, Inc. | $174.8M | — |
| BCDA | BioCardia, Inc. | $180.0M | — |
| ALGS | Aligos Therapeutics, Inc. | $181.1M | — |
| ACOG | Alpha Cognition Inc. | $183.1M | — |
| CRBU | Caribou Biosciences, Inc. | $147.8M | — |
| VYGR | Voyager Therapeutics, Inc. | $183.7M | — |
| LENZ | LENZ Therapeutics, Inc. | $184.4M | — |
| DTIL | PRECISION BIOSCIENCES INC | $185.0M | — |
| PLX | Protalix BioTherapeutics, Inc. | $187.7M |
| — |
| CRIS | CURIS INC | $188.3M | — |
